KRAS and colorectal carcinoma: It is noteworthy that although in the CMS classification of CRC, KRAS mutation is enriched in the CMS3-metabolic subtype, our data do not suggest AA patients have more CMS3 subtypes of CRC, as KRAS mutation are also present in other subtypes in low frequency [20].